Specific GR binding sites/cell (Bmax) and receptor affinity for ligand (KD) values for ALL xenografts
Xenograft . | Bmax (sites/cell) . | KD (nM) . |
|---|---|---|
| ALL-2 | 9 762 ± 446 | 8.4 ± 1.3 |
| ALL-3 | 8 931 ± 314 | 5.9 ± 0.7 |
| ALL-4 | 6 555 ± 222 | 4.6 ± 0.6 |
| ALL-7 | 15 794 ± 543 | 4.1 ± 0.6 |
| ALL-8 | 1 752 ± 140 | 5.5 ± 1.6 |
| ALL-10 | 8 713 ± 435 | 11.0 ± 1.8 |
| ALL-16 | 7 117 ± 247 | 4.9 ± 0.7 |
| ALL-17 | 8 772 ± 236 | 3.9 ± 0.5 |
| ALL-18 | 9 432 ± 296 | 5.3 ± 0.6 |
| ALL-19 | 7 149 ± 294 | 2.7 ± 0.5 |
Xenograft . | Bmax (sites/cell) . | KD (nM) . |
|---|---|---|
| ALL-2 | 9 762 ± 446 | 8.4 ± 1.3 |
| ALL-3 | 8 931 ± 314 | 5.9 ± 0.7 |
| ALL-4 | 6 555 ± 222 | 4.6 ± 0.6 |
| ALL-7 | 15 794 ± 543 | 4.1 ± 0.6 |
| ALL-8 | 1 752 ± 140 | 5.5 ± 1.6 |
| ALL-10 | 8 713 ± 435 | 11.0 ± 1.8 |
| ALL-16 | 7 117 ± 247 | 4.9 ± 0.7 |
| ALL-17 | 8 772 ± 236 | 3.9 ± 0.5 |
| ALL-18 | 9 432 ± 296 | 5.3 ± 0.6 |
| ALL-19 | 7 149 ± 294 | 2.7 ± 0.5 |